Three Distinct Two-Component Systems Are Involved in Resistance to the Class I Bacteriocins, Nukacin ISK-1 and Nisin A, in Staphylococcus aureus

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kawada Matsuo, Miki ^a   Yoshida, Yuuma ^a   Zendo, Takeshi ^b   Nagao, Junichi ^c   Oogai, Yuichi ^a   Nakamura, Yasunori ^a   Sonomoto, Kenji ^b   Nakamura, Norifumi ^a   Komatsuzawa, Hitoshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER BRAAB; ABC TRANSPORTER VRADE; ABC TRANSPORTER VRAFG; BACTERIAL PROTEIN; BACTERIOCIN; NISIN A; NUKACIN ISK 1; PROTEIN BRARS; PROTEIN GRARS; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TWO COMPONENT SYSTEM; BACTERIUM MUTANT; BRARS GENE; COCULTURE; CONTROLLED STUDY; EVOLUTIONARY ADAPTATION; GENE; GENE CONTROL; GENE INACTIVATION; GENE INTERACTION; GRARS GENE; LACTOBACILLUS DELBRUECKII; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN PROTEIN INTERACTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS WAMERI; UPREGULATION; VRADE GENE; VRASR GENE; WILD TYPE;

ATP-BINDING CASSETTE TRANSPORTERS; BACTERIOCINS; COCULTURE TECHNIQUES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; LACTOCOCCUS LACTIS; MUTATION; NISIN; STAPHYLOCOCCUS AUREUS;

EID: 84880669240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069455     Document Type: Article

References (51)

1. Cotter PD, Hill C, Ross RP, (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788.
2. Nissen-Meyer J, Nes IF, (1997) Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Arch Microbiol 167: 67-77.
3. Asaduzzaman SM, Sonomoto K, (2009) Lantibiotics: diverse activities and unique modes of action. J Biosci Bioeng 107: 475-487.
4. Klaenhammer TR, (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12: 39-85.
5. Nissen-Meyer J, Rogne P, Oppegard C, Haugen HS, Kristiansen PE, (2009) Structure-function relationships of non-lanthionine containing peptide (class II) bacteriocins produced by gram-positive bacteria. Curr Pharm Biotechnol 10: 19-37.
6. Jung G (1991) Lantibiotics: a survey, p. 1-34. In G. Jung and H.-G. Sahl (ed.), Nisin and novel lantibiotics. ESCOM, Leiden, The Netherlands.
7. Hyde AJ, Parisot J, McNichol A, Bonev BB, (2006) Nisin-induced changes in Bacillus morphology suggest a paradigm of antibiotic action. Proc Natl Acad Sci USA 103: 19896-19901.
8. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, et al. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276: 1772-1779.
9. de Kruijff B, van Dam V, Breukink E, (2008) Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics. Prostaglandins Leukot Essent Fatty Acids 79: 117-121.
10. Islam MR, Nishie M, Nagao J, Zendo T, Keller S, et al. (2012) Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J Am Chem Soc 134: 3687-3690.
11. Asaduzzaman SM, Nagao J, Iida H, Zendo T, Nakayama J, et al. (2009) Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob Agents Chemother 53: 3595-3598.
12. Foster TJ, (2004) The Staphylococcus aureus "superbug". J Clin Invest 114: 1693-1696.
13. Lowy FD, (1998) Staphylococcus aureus infections. New Engl J Med 339: 520-532.
14. Manders SM, (1998) Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 39: 383-398.
15. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, et al. (2007) The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 13: 222-235.
16. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E, (2006) Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368: 874-875.
17. Gardete S, Wu SW, Gill S, Tomasz A, (2006) Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob Agents Chemother 50: 3424-3434.
18. Matsuo M, Kato F, Oogai Y, Kawai T, Sugai M, et al. (2010) Distinct two-component systems in methicillin-resistant Staphylococcus aureus can change the susceptibility to antibacterial agents. J Antimicrob Chemother 65: 1536-1537.
19. Meehl M, Herbert S, Götz F, Cheung A, (2007) Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother 51: 2679-2689.
20. Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, et al. (2002) Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 46: 1492-1502.
21. Eguchi Y, Utsumi R, (2008) Introduction to bacterial signal transduction networks. Adv Exp Med Biol 631: 1-6.
22. Mitrophanov AY, Groisman EA, (2008) Signal integration in bacterial two-component regulatory systems. Genes Dev 22: 2601-2611.
23. Yoshida Y, Matsuo M, Oogai Y, Kato F, Nakamura N, et al. (2011) Bacitracin sensing and resistance in Staphylococcus aureus. FEMS Microbiol Lett 320: 33-39.
24. Hiron A, Falord M, Valle J, Débarbouillé M, Msadek T, (2011) Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol 81: 602-622.
25. Blake KL, Randall CP, O'Neill AJ, (2011) In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance. Antimicrob Agents Chemother 55: 2362-2368.
26. Kolar SL, Nagarajan V, Oszmiana A, Rivera FE, Miller HK, et al. (2011) NsaRS is a cell-envelope-stress sensing two-component system of Staphylococcus aureus. Microbiology 157: 2206-2219.
27. Cook HA, Cimiotti JP, Della-Latta P, Saiman L, Larson EL, (2007) Antimicrobial resistance patterns of colonizing flora on nurses' hands in the neonatal intensive care unit. Am. J Infect Control 35: 231-236.
28. Nagase N, Sasaki A, Yamashita K, Shimizu A, Wakita Y, et al. (2002) Isolation and species distribution of staphylococci from animal and human skin. J Vet Med Sci 64: 245-250.
29. Komatsuzawa H, Suzuki J, Sugai M, Miyake Y, Suginaka H, (1994) The effect of Triton X-100 on the in-vitro susceptibility of methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrob Chemother. 34: 885-897.
30. Fujita K, Ichimasa S, Zendo T, Koga S, Yoneyama F, et al. (2007) Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl Environ Microbiol 73: 2871-2877.
31. Aso Y, Okuda K, Nagao J, Kanemasa Y, Thi Bich Phuong N, et al. (2005) A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci Biotechnol Biochem. 69: 1403-1410.
32. Barefoot SF, Klaenhammer TR, (1983) Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol 45: 1808-1815.
33. Lin WS, Cunneen T, Lee CY, (1994) Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus. J Bacteriol 176: 7005-7016.
34. Luong TT, Lee CY, (2006) The arl locus positively regulates Staphylococcus aureus type 5 capsule via an mgrA-dependent pathway. Microbiology 152: 3123-3131.
35. Komatsuzawa H, Fujiwara T, Nishi H, Yamada S, Ohara M, et al. (2004) The gate controlling cell wall synthesis in Staphylococcus aureus. Mol Microbiol 53: 1221-1231.
36. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, et al. (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193: 1067-1076.
37. Manson JM, Keis S, Smith JM, Cook GM, (2004) Acquired bacitracin resistance in Enterococcus faecalis is mediated by an ABC transporter and a novel regulatory protein, BcrR. Antimicrob Agents Chemother 48: 3743-3748.
38. Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, et al. (2003) The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol Microbiol 49: 1135-1144.
39. Podlesek Z, Comino A, Herzog-Velikonja B, Zgur-Bertok D, Komel R, et al. (1995) Bacillus licheniformis bacitracin-resistance ABC transporter: relationship to mammalian multidrug resistance. Mol Microbiol 16: 969-976.
40. Ouyang J, Tian XL, Versey J, Wishart A, Li YH, (2010) The BceABRS four-component system regulates the bacitracin-induced cell envelope stress in Streptococcus mutans. Antimicrob Agents Chemother 54: 3895-3906.
41. Falord M, Mäder U, Hiron A, Débarbouillé M, Msadek T, (2011) Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS One 6: e21323.
42. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, et al. (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66: 1136-1147.
43. Matsuo M, Oogai Y, Kato F, Sugai M, Komatsuzawa H, (2011) Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology 157: 1786-1797.
44. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, et al. (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274: 8405-8410.
45. Falord M, Karimova G, Hiron A, Msadek T, (2012) GraXSR proteins interact with the VraFG ABC transporter to form a five component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob Agents Chemother 56: 1047-1058.
46. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, et al. (2003) Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49: 807-821.
47. Belcheva A, Golemi-Kotra D, (2008) A close-up view of the VraSR two-component system. A mediator of Staphylococcus aureus response to cell wall damage. J Biol Chem 283: 12354-12364.
48. McCallum N, Meier PS, Heusser R, Berger-Bächi B, (2011) Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus. Antimicrob Agents Chemother 55: 1391-1402.
49. Muthaiyan A, Silverman JA, Jayaswal RK, Wilkinson BJ, (2008) Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother 52: 980-990.
50. Chandrapati S, O'Sullivan DJ, (2002) Characterization of the promoter regions involved in galactose- and nisin-mediated induction of the nisA gene in Lactococcus lactis ATCC 11454. Mol Microbiol 46: 467-477.
51. Aso Y, Koga H, Sashihara T, Nagao J, Kanemasa Y, et al. (2005) Description of complete DNA sequence of two plasmids from the nukacin ISK-1 producer, Staphylococcus warneri ISK-1.Plasmid. 53: 164-178.